Big Biotech Set for Earnings Blowout?


Earlier this year, Oppenheimer's Hartaj Singh argued that earnings expectations were too high for big biotech companies heading into the first-quarter reporting season. However, as we approach the second-quarter, he thinks things may be looking up.



from Biotech News